The treatment of oligometastatic disease using MR guidance is an evolving field. Since August 2018 patients are treated on a 1.5 Tesla MR-Linac (MRL). We present current workflows and practice standards from seven institutions for the initial patients treated for lymph node and liver metastases.
Keywords: (3–6): oligometastases; MOMENTUM; MR-Linac; MR-guided radiotherapy; SABR.
© 2022 The Author(s).